Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/27/2003EP1337514A1 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
08/27/2003EP1337510A2 Synthesis and antimicrobial activityof novel dicationic "reversed amidines"
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337252A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria
08/27/2003EP1337152A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/27/2003EP1337149A2 Vaccine immunotherapy for immune suppressed patients
08/27/2003EP1296703A4 Non-antibacterial tetracycline as anti-fungal agents
08/27/2003EP1193266B1 Quinolinecarboxylic acid derivative or salts thereof
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids
08/27/2003EP1157030B1 Echinocandin/carbohydrate complexes
08/27/2003EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
08/27/2003EP1124831B1 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1073672B1 Antipicornaviral compounds, their preparation and use
08/27/2003EP1059845B1 Fungicide composition comprising a benzoylphenylurea
08/27/2003EP0946567B1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
08/27/2003EP0906089B1 Buccal delivery system
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0833657B1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
08/27/2003EP0821693B1 Novel human cytomegalovirus dna sequences
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003CN1439056A Herpes viruses for immune modulation
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439014A Novel cephalosporin compounds and process for preparing the same
08/27/2003CN1439013A Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
08/27/2003CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá"
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438889A Sustained-release preparations of quinolone antibiotics and method for prepartion thereof
08/27/2003CN1438888A 稳定的液体制剂 Stable liquid formulation
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438880A Method for preparing a composition
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438874A Powder compositions
08/27/2003CN1438866A Medical product package for eradication therapy
08/27/2003CN1438247A Anti-mastitis causative-agent composite yolk antiboy for milk cow and its preparation and use
08/27/2003CN1438246A Anti-yellow-dysenteryÒÇüanti-white-dysentery causative-agent yolk antibody for young pig and its preparation and use
08/27/2003CN1438245A Infectious causative-agent related egg-yolk antibody preparation and use thereof
08/27/2003CN1438238A Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
08/27/2003CN1438225A Ginger-yellow pigment metal-ion complex, its preparation method and use
08/27/2003CN1438038A Chinese medicine formula for preventing common cold by fumigating air to act respiratory tract and using method
08/27/2003CN1438032A Compound preparation for dissolving staphyloase and preparation method
08/27/2003CN1438031A Medicine for resisting tuberculosis and preparation method
08/27/2003CN1438026A Medicine for treating venereal disease and urinary system disease and production method and use
08/27/2003CN1438023A Chinese preporatory medicine for treating lung disease
08/27/2003CN1438017A Medicine for treating common cold and preparation method
08/27/2003CN1437994A Ascites pill and its preparation method
08/27/2003CN1437991A Medicine for treating bacterial vaginal disease
08/27/2003CN1437990A Heat-clearing and toxicant-eliminating preparation and preparation method
08/27/2003CN1437989A Method for preparing Gongjinle medicinal liquor for treating tracheitis
08/27/2003CN1437982A Medicinal composition for treating mycoplasma pneumonia and preparation method and quality-control method
08/27/2003CN1437975A Medicine for treating common cold
08/27/2003CN1437969A Chinese medicine preparation for treating hepatitis B and preparation method
08/27/2003CN1437963A Medicine for treating common cold and preparation method
08/27/2003CN1437960A Chinese medicine for treating chronic bronchitisÒÇütuberculosis and asthma
08/27/2003CN1437957A Method for producing whole silkworm powder milk-containing and ferritin
08/27/2003CN1437947A Ofloxacin eye ointment
08/27/2003CN1437946A Medicine-release system of compound Rifampicin
08/27/2003CN1437940A Fluconazole oral tablet capable of quickly disintegrating and dissolving out and preparation process
08/27/2003CN1437939A Method for induding andrographolide by cyclodextrin and medicinal preparation
08/27/2003CN1437937A Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof
08/27/2003CN1437936A Libaweilin slow-released pill
08/27/2003CN1437933A Method for preparing Rifampiciu microballs covered by degradable high-molecular material
08/27/2003CN1119351C Cyclic adhesion inhibitors
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119171C Pharmaceutical using of bradykinin-antagonist in preparation of drug for treating uiral illness
08/27/2003CN1119146C Compositions and kits for increasing the oral bioavailability of pharmaceutical agents
08/26/2003US6610842 Removing hydroxyl protecting group from compound of given formula and treating with another compound; wide range of diagnostic and therapeutic uses
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections
08/26/2003US6610745 Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-KS
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610735 Coadministration of a an oral bioavailability-enhancing agent (e.g., a cyclosporin F or ketoconazole) with a drug that exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide)
08/26/2003US6610730 Viricides; protease inbhibitor
08/26/2003US6610725 Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
08/26/2003US6610723 Imidazole derivatives
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610714 Non-nucleoside reverse transcriptase inhibitors
08/26/2003US6610698 Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease
08/26/2003US6610689 Viricides
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610327 Oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
08/26/2003US6610319 Immune response modifier compounds for treatment of TH2 mediated and related diseases
08/26/2003US6610314 Comprising one or more proton donating agents and an alkyl phosphate anionic surfactant: high activity against numerous bacteria and other microorganisms
08/26/2003US6610309 Vaccines; mixture of antigen and water solubility organometallic compound
08/26/2003US6610308 Immunostimulant emulsion
08/26/2003US6610307 Immunity against pasteurella haemolytica leukotoxin
08/26/2003US6610305 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
1 ... 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 ... 1798